Mizuho Securities USA’s Moderna MRNA Stock Holding History

Mizuho Securities USA’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.94M	Buy	27,647 +6,624	+32%	+$343K	0.03%	447
2026 Q1	$1.07M	Sell	21,023 -4,295	-17%	-$200K	0.03%	530
2025 Q4	$659K	Buy	25,318 +97	+0.4%	+$2.63K	0.01%	634
2025 Q3	$608K	Buy	25,221 +1,695	+7%	+$47.3K	0.01%	646
2025 Q2	$649K	Sell	23,526 -3,589	-13%	-$94.5K	0.01%	609
2025 Q1	$769K	Sell	27,115 -4,980	-16%	-$177K	0.02%	570
2024 Q4	$1.33M	Buy	32,095 +10,160	+46%	+$486K	0.02%	502
2024 Q3	$1.47M	Sell	21,935 -3,775	-15%	-$347K	0.03%	416
2024 Q2	$3.05M	Buy	+25,710	New	+$3.25M	0.07%	265

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Mizuho Securities USA's MRNA Position: Q2 2026 in Review

Mizuho Securities USA increased its Moderna (MRNA) stake by 32% in Q2 2026, buying an estimated $343K and bringing the position to 27,647 shares worth $1.94M. The position accounts for 0.03% of the portfolio, ranked #447.

Mizuho Securities USA first reported a position in MRNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.05M in Q2 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Mizuho Securities USA held 27,647 shares of Moderna worth $1.94M as of Q2 2026.
Mizuho Securities USA bought 6,624 Moderna shares in Q2 2026, an estimated $343K.
Moderna made up 0.03% of Mizuho Securities USA's portfolio in Q2 2026, its #447 holding.
Mizuho Securities USA first reported a position in Moderna in Q2 2024 and has held it in 9 quarters since.
Mizuho Securities USA's Moderna position peaked at $3.05M in Q2 2024.
784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.